Listen

Description

(Watch the video interview HERE)



In this interview, CEO Martin Gouldstone of Oncimmune (ONC) - a global leader in immune biomarkers and immunodiagnostics – takes Vox Markets through:



00:00 His first impressions of the business & how ONC's services are used in the field.

07:00 Revised commercial strategy

17:45 Current health of the sector

21:20 Size of the addressable market

28:55 Roadmap & timelines ahead